scispace - formally typeset
N

Nobuyuki Sato

Researcher at Tohoku University

Publications -  81
Citations -  1095

Nobuyuki Sato is an academic researcher from Tohoku University. The author has contributed to research in topics: Lung cancer & Harmonic. The author has an hindex of 18, co-authored 78 publications receiving 1040 citations.

Papers
More filters
Journal ArticleDOI

Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy.

TL;DR: The data presented here suggest that systemic DNA/RNA oxidation is commonly observed in neurodegenerative diseases and implies that female patients with PD show higher levels of oxidative stress, which may explain the faster progression of this disease in females.
Journal ArticleDOI

Neuro-Sweet Disease: Benign Recurrent Encephalitis With Neutrophilic Dermatosis

TL;DR: It is proposed that there is an entity that is like Sweet disease, but with recurrent encephalitis characterized by an association with HLA-B54 and a high responsiveness to corticosteroid therapy, which is tentatively named neuro-Sweet disease, that is distinct from the classic central nervous system involvement of Behçet disease.
Journal ArticleDOI

A prospective study of surgical procedures for patients with oligometastatic non-small cell lung cancer.

TL;DR: Clinical T1-2N0-1 lung cancer with a single-organ metastatic lesion was a good candidate for surgical resection, and a 5-year survival rate could be comparable with that for stage II non-small cell lung cancer.
Journal ArticleDOI

Highly efficient operation of space harmonic peniotron at cyclotron high harmonics

TL;DR: In this paper, the oscillation characteristics of cyclotron high-harmonic peniotrons based on space harmonic interactions in magnetron waveguide resonators were described and the experimental results showed extremely high electronic efficiencies of 75% and 6% at 30 and 100 GHz, respectively.
Journal ArticleDOI

Combined analysis of cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer.

TL;DR: Findings indicate that combined immunohistochemical analysis of COX-2 with p53 and Ki-67 can be useful for identifying the prognosis of NSCLC patients.